Incyte Corporation (ICY)
FSX
Real-time Data
06:00 AM
Day's Range
109.8552 wk Range
69.58Overview - ICY - Incyte Corporation
Key Statistics
Valuation
Enterprise Value
15.37B
P/E (Trailing)
‪16.50‬
P/E (Forward)
‪25.11‬
PEG Ratio
‪0.41‬
Price / Sales (TTM)
‪3.85‬
Price / Book
‪4.09‬
EV / EBITDA
‪9.24‬
Profitability
Gross Margin
‪93.72%‬
Profit Margin
‪27.70%‬
Operating Margin
‪41.89%‬
Return on Assets
‪16.83%‬
Return on Equity
‪30.66%‬
Ownership
Shares Outstanding
200.97M
Float
170.74M
Held by Insiders
‪1.83%‬
Held by Institutions
‪103.83%‬
Price stats
Beta
‪0.76‬
50-Day Avg
‪100.65‬
200-Day Avg
‪88.61‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - ICY - Incyte Corporation
Peers - ICY - Incyte Corporation
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- ICYFSXIncyte Corporation22.44BMarket Cap+34.52%52-week change16.51P/E (Trailing)‪27.70%‬Profit Margin
- ANLFSXAnalog Devices, Inc.155.74BMarket Cap+33.03%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- 1AEFSXargenx SE54.66BMarket Cap+32.95%52-week change39.15P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt54.41BMarket Cap+34.86%52-week change38.91P/E (Trailing)‪32.26%‬Profit Margin
- 0QFFSXModerna, Inc.50.02BMarket Cap+81.89%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 42ZFSXRevolution Medicines Inc.38.84BMarket Cap+82.79%52-week change-30.46P/E (Trailing)‪0.00%‬Profit Margin
- 49BAFSXBeOne Medicines, Ltd. American Depositary Receipt35.97BMarket Cap+14.46%52-week change66.67P/E (Trailing)‪10.69%‬Profit Margin
Profile Summary - ICY - Incyte Corporation
About
Incyte Corporation is a biopharmaceutical company that focuses on the discovery, development, and commercialization of proprietary therapeutics for serious medical conditions. The company concentrates on hematology and oncology, as well as inflammation, autoimmunity, and dermatology, addressing diseases with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
